AbbVie

ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.754%

12M weight contribution

+0.032 pp

3M weight contribution

-0.000 pp

12M price return

+25.3%

Share of matched S&P 500 members

Monthly observations through Jan 2026

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Jan 2026	$394.1bn	0.754%	+0.032 pp	+25.3%	No
Dec 2025	$403.8bn	0.791%	+0.079 pp	+33.1%	Yes
Nov 2025	$402.4bn	0.791%	+0.077 pp	+28.8%	Yes
Oct 2025	$385.2bn	0.755%	-0.092 pp	+10.7%	Yes
Sep 2025	$409.0bn	0.819%	+0.007 pp	+21.4%	Yes
Aug 2025	$371.7bn	0.771%	-0.067 pp	+11.0%	No
Jul 2025	$333.9bn	0.704%	+0.118 pp	+5.6%	No
Jun 2025	$327.9bn	0.707%	+0.139 pp	+12.2%	No
May 2025	$328.7bn	0.745%	+0.201 pp	+19.6%	No
Apr 2025	$344.4bn	0.827%	-0.005 pp	+24.3%	Yes
Mar 2025	$369.9bn	0.878%	-0.014 pp	+19.2%	Yes
Feb 2025	$369.0bn	0.825%	-0.066 pp	+23.1%	Yes
Jan 2025	$325.0bn	0.723%	-0.140 pp	+15.9%	No
Dec 2024	$314.0bn	0.712%	-0.104 pp	+18.9%	No
Nov 2024	$323.3bn	0.713%	-0.070 pp	+33.2%	No
Oct 2024	$360.1bn	0.846%	-0.001 pp	+49.7%	Yes
Sep 2024	$348.8bn	0.812%	-0.067 pp	+37.6%	Yes
Aug 2024	$346.8bn	0.838%	+0.011 pp	+38.7%	Yes
Jul 2024	$327.3bn	0.587%	+0.011 pp	+28.7%	No
Jun 2024	$302.9bn	0.568%	+0.018 pp	+32.5%	No
May 2024	$284.7bn	0.544%	-0.057 pp	+21.6%	No
Apr 2024	$287.3bn	0.832%	-0.071 pp	+12.0%	No
Mar 2024	$321.7bn	0.892%	-0.070 pp	+18.9%	Yes
Feb 2024	$311.0bn	0.891%	-0.066 pp	+19.0%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.